#MuscadineIngredient – Chris Paulk

August 13, 2026

The MPC Research File: Every Published Study on Muscadine, Accurately Scoped

If you’re making a sourcing decision about muscadine, you need to know exactly what the published research shows — not a summary, not a highlight reel. Every study specifically on muscadine relevant to supplement formulation, with design, population, and findings clearly stated.

If you’re a formulator evaluating muscadine as an ingredient, this is your research starting point. Share it with your R&D team. Let your regulatory counsel work from these citations. Build your formula on what the research supports.

Study 1: Banini et al. — Metabolic Markers in T2D Subjects

Banini AE et al. Nutrition 2006; 22(11–12):1137–1145. North Carolina State University.
Study type	Dietary intervention. Non-randomized. 28 days.
Population	Type 2 diabetic subjects (assigned to muscadine juice, wine, or dealcoholized wine) and non-diabetic subjects (juice only)
Intervention	150 mL/day of muscadine grape juice, wine, or dealcoholized wine with meals
Key finding	Diabetics given muscadine wine and dealcoholized wine showed lower blood glucose, insulin, and glycated hemoglobin compared to diabetics given juice. Significant improvement in fasting insulin only in the dealcoholized wine group.
Limits	Non-diabetic group received juice only — no comparison arm across product types. No placebo control. Beverage forms only — not encapsulated extract. Cannot generalize findings to healthy populations.

What this gives a formulator: peer-reviewed human research on muscadine and metabolic markers in a population where those markers matter. What it doesn’t give: evidence of metabolic benefit in healthy adults or in capsule supplement form.

Study 2: Mellen et al. — Cardiovascular Markers in Cardiac Risk Population

Mellen PB et al. J Am Coll Nutr 2010; 29(5):469–475. Hypertension Center of Excellence, Hattiesburg Clinic.
Study type	Randomized, double-blind, placebo-controlled crossover trial. 4 weeks each, 4-week washout.
Population	50 adults with coronary disease or ≥1 cardiac risk factor
Intervention	Muscadine grape seed supplement at 1,300 mg/day vs. placebo
Key finding	Primary endpoint (FMD): not statistically significant (p=0.06). Secondary finding: significant increase in resting brachial diameter (p=0.002) — clinical significance not yet established. No significant change in inflammation, lipid peroxidation, or antioxidant capacity biomarkers.
Limits	Primary endpoint not met. Secondary finding of unclear clinical significance. Authors called for more research.

What this gives a formulator: one of the most rigorous study designs in nutritional science, applied specifically to muscadine grape seed in a cardiovascular risk population. That research credential is real, even though the primary endpoint wasn’t met. What it doesn’t give: evidence of cardiovascular benefit.

Study 3: Ghanim et al. — Oxidative Stress in a Meal Challenge

Ghanim H et al. J Clin Endocrinol Metab 2011; 96(5):1409–1414. State University of New York at Buffalo.
Study type	Human meal challenge trial. Randomized crossover with placebo. 10 subjects.
Population	10 healthy adults. High-fat, high-carbohydrate meal challenge.
Intervention	Combination supplement containing resveratrol AND muscadine grape polyphenols — not muscadine alone
Key finding	The combination supplement reduced meal-induced oxidative and inflammatory stress markers and stimulated Nrf-2 antioxidant transcription factor activity compared to placebo.*
Limits	Combination supplement — muscadine’s specific contribution cannot be isolated from resveratrol’s. Small study (n=10). Meal challenge context only, not general supplementation.

What this gives a formulator: peer-reviewed human evidence that a resveratrol-and-muscadine polyphenol combination affected oxidative stress markers during a meal challenge, including Nrf-2 activation. What it doesn’t give: evidence that muscadine alone produces these effects, or that the same effects occur in a general supplementation context.

Study 4: Patil et al. — Cardiac Damage in an Animal Hypertension Model

Patil PD et al. Antioxidants 2022; 11(10):2026. Wake Forest University School of Medicine.
Study type	Animal model study. Rodent (Sprague Dawley rats). 4 weeks.
Population	Male rats with angiotensin II-induced hypertension
Intervention	Muscadine grape skin/seed extract supplement vs. control
Key finding	MGES did not affect blood pressure but attenuated hypertension-induced diastolic dysfunction markers (E/e’ ratio) in the animal model. Researchers observed reductions in oxidative stress markers and macrophage infiltration in cardiac tissue.
Limits	Animal model only — findings in rats do not directly establish human outcomes. Results are mechanistic and hypothesis-generating, not clinically conclusive.

What this provides a formulator: peer-reviewed research from Wake Forest University School of Medicine on a muscadine skin/seed extract and cardiovascular-relevant endpoints in an animal model. What it doesn’t provide: human clinical evidence.

What the Full Research File Means for Your Formula

Four published studies specifically on muscadine. Two human trials, one human meal challenge using a combination supplement, and one animal model. That’s a meaningful research base for a botanical ingredient — and we’re presenting every limitation alongside every finding so your team can evaluate them accurately.

Here’s what you can build on, honestly:

Muscadine has been studied in peer-reviewed human research in metabolic and cardiovascular contexts — areas where formulators face the most scrutiny over ingredient credentials
The research spans three institutions: North Carolina State University, Hattiesburg Clinic, and Wake Forest University School of Medicine.
The compound profile studied — skin, seed, juice, and combination forms — maps directly to the ingredient forms MPC supplies.
No study produced a definitive positive primary outcome in a healthy general population, so your label claims need to be based on structure/function language, with guidance from regulatory counsel
Your regulatory counsel and R&D team are best positioned to determine how this research base supports your specific formula and claims.

Paulk Vineyards grows muscadines. MPC processes everything on-site. 800+ acres in Wray, Georgia. Seventh generation on the farm, fourth with muscadines. We can provide full documentation for every study cited here.

Request the full research file or a sample at muscadineproducts.com.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Research references cited include human dietary intervention studies, a human meal-challenge trial using a combination supplement, and an animal model study. Findings from each study reflect what was observed in the specific study population and design described; they do not establish that any MPC muscadine ingredient product produces the same effects. The Ghanim et al. (2011) study used a combination of resveratrol and muscadine polyphenols; muscadine’s independent contribution cannot be isolated from that data. The Patil et al. (2022) study was conducted in an animal model; findings do not directly establish human outcomes. Formulators should consult qualified regulatory counsel before establishing label claims for finished consumer products.

Muscadine Products Corporation • Wray, Georgia • muscadineproducts.com

August 4, 2026

What the Polyphenol-Vascular Research Landscape Tells a Formulator — and What Muscadine Brings to It

Wray, Georgia, evening light over the lake. Some weeks get away from you. The vine keeps growing regardless.

If you’ve been following this cardiovascular series, you have the research pieces — the Mellen study breakdown, the credibility bar, the CFIC consumer signal. What ties it all together is the broader polyphenol-vascular research landscape: where does muscadine actually sit within the published science?

That’s what this week covers.

If you’re evaluating muscadine for a cardiovascular formula, this is the post that completes the picture.

The Polyphenol-Vascular Research Base: What’s There

The body of published human research on dietary polyphenols and vascular health is substantial and growing. A 2022 systematic review in Nutrients by Grosso et al. examined evidence from human studies on dietary polyphenol intake, blood pressure, and vascular health. The review found associations between polyphenol-rich food intake — particularly anthocyanin-rich fruits — and blood pressure outcomes, with proposed mechanisms including modulation of the nitric oxide pathway and antioxidant activity in vascular tissue. *

The nitric oxide pathway is worth understanding because it’s central to how polyphenols are thought to influence vascular function. A 2023 review by Serreli and Deiana in Antioxidants examined dietary polyphenols and nitric oxide synthase activity across in vivo and in vitro studies. The proposed mechanism: polyphenols modulate signaling pathways that regulate endothelial nitric oxide synthase (eNOS), the enzyme responsible for producing nitric oxide in blood vessel walls. According to the reviewed literature, nitric oxide plays a key role in regulating vascular tone. *

For a formulator, understanding this mechanism matters because it links an ingredient’s phytochemical profile to a documented biological pathway — exactly the scientific rationale your R&D team needs before building a cardiovascular formula.

Where Grape-Derived Polyphenols Specifically Stand

A 2025 narrative review in Food & Function examined the impact of polyphenol-rich foods on flow-mediated dilation (FMD) — the same primary measure used in the Mellen study — across 97 published studies. The finding relevant to muscadine: grape-derived polyphenols showed a wide range of FMD responses across studies (0.8–8.7%), and the authors noted that effects are difficult to substantiate without detailed compositional or metabolomic data. *

That finding provides important context for the Mellen study. The null primary FMD result we’ve discussed throughout this month isn’t unusual for grape-derived polyphenols in the literature — FMD responses in this class vary across studies, with multiple factors affecting outcomes, including polyphenol form, dose, bioavailability, and study population. The Mellen study sits within a broader research landscape in which grape polyphenol effects on FMD are genuinely complex and not yet fully characterized.

That doesn’t diminish muscadine’s research credentials. It places them accurately within the science itself.

What Muscadine Brings to This Landscape

Muscadine (Vitis rotundifolia) contributes a well-characterized phytochemical profile to this research context: anthocyanins, OPCs, ellagic acid, and resveratrol — compounds that appear throughout the polyphenol-vascular literature. The anthocyanin content places muscadine within the compound class examined in the Grosso review’s findings on anthocyanin-rich foods and blood pressure associations. The OPC profile is examined in the context of vascular tone research. The ellagic acid and resveratrol content has been studied for their potential roles in antioxidant and anti-inflammatory pathways relevant to cardiovascular research. *

What muscadine adds that most grape-derived polyphenol ingredients don’t: a distinct botanical species with a documented phytochemical profile, a fully traceable domestic estate supply chain, and a peer-reviewed human trial in a cardiovascular risk population. The Mellen trial’s null primary result is part of the honest picture. So is the fact that it’s one of the very few randomized cardiovascular trials in the botanical supplement space.

Paulk Vineyards grows muscadines — 800+ acres in Wray, Georgia, seventh generation on the farm, fourth with muscadines. MPC processes everything on-site. That traceability allows a formulator to link the ingredient in their formula to the same botanical source studied in peer-reviewed research.

What’s Coming in August

Next week: Antioxidants + The Science. We’re compiling every published study relevant to muscadine — the full research file, accurately scoped, with populations and designs clearly stated. If you want to know exactly what the science shows before making a sourcing decision, that’s the post to read.

If you’re ready to start the sourcing conversation now — before the August research file is posted — request a sample or documentation at muscadineproducts.com.

July 28, 2026

What Produce Buyers at CFIC Were Asking About Muscadines — and Why It Matters to Formulators

If you’re sourcing a polyphenol ingredient and looking for one with a consumer story already taking shape, this week’s post is worth reading before you make that decision.

We were in Myrtle Beach last week for the Carolina Food Industry Conference. My dad, Gary, and I attended as Crystal Sponsors, and most of our conversations focused on the produce and wine tracks — discussing fresh muscadines, flavor, regional identity, and what the category looks like heading into harvest.

One thread kept coming up in those conversations that I want to revisit in this series: consumer interest in muscadines.

Produce buyers are practical people. They stock what moves. What they told us, more than once, is that consumer curiosity about the health benefits of fresh muscadines is growing. Not in a clinical-trial kind of way — in a ‘my customer is asking questions, and I want to be able to answer them’ kind of way. They wanted to know what makes muscadines different from conventional grapes, what the science behind them looks like, and how to communicate that to customers.

For a formulator following this series, that conversation matters more than it appears.

Why Consumer Produce Interest Creates Formulator Opportunity

When produce buyers start asking about health benefits, it’s usually a sign that consumer awareness is ahead of the retail category. People are already researching muscadines, reading about polyphenols, and asking questions at the store level. That awareness doesn’t stay in the produce aisle.

Consumers who discover muscadines as a health food — through the fresh market, regional media, or word of mouth in the Southeast — become consumers who look for muscadine on supplement labels. The fresh market and the supplement market aren’t separate conversations. They’re the same consumer at different points in their journey with the fruit.

For a formulator building in polyphenol categories — antioxidants, cardiovascular, metabolic, and gut health — growing consumer name recognition for muscadine is a brand asset, not just a farming metric. It means your label can say ‘muscadine’ and more consumers will know what it means than did five years ago.

What Makes Muscadine Different — The Version We Shared at CFIC

The conversation with produce buyers wasn’t technical. It was about flavor, story, and place. Muscadines (Vitis rotundifolia) are native to the American Southeast — a distinct species from the conventional wine grape (Vitis vinifera) most people think of when they hear ‘grape.’ Their flavor is fuller and more complex. Their skin is thicker. Their seeds are larger. And their phytochemical profile — ellagic acid, OPCs, anthocyanins, resveratrol — is meaningfully different from that of vinifera-derived ingredients.

That distinctiveness is exactly what produce buyers want to communicate to their customers. It’s also exactly what formulators can build on when they source muscadine as an ingredient — a documented phytochemical profile from a distinct botanical species with a regional identity that most polyphenol ingredients can’t match.

Paulk Vineyards grows more than 800 acres of muscadines in Wray, Georgia — seventh generation on the farm, fourth with muscadines. The fruit that goes into MPC’s ingredient forms is the same fruit that produce buyers increasingly put in the fresh case. One estate. One supply chain. One story.

What This Means for Your Formula Right Now

If you’re building a supplement that features muscadine as a named ingredient, consumer awareness is working in your favor in a way it wasn’t a decade ago. The regional identity is established in the Southeast, and consumer interest is expanding beyond that region. The conversation about consumer interest is already happening at the retail level. And the phytochemical profile gives your R&D team a documented starting point for the formulation conversation.

We’ll be back to the cardiovascular research series next week — the post on the polyphenol and vascular function landscape that was scheduled before the conference. The fresh market signal we heard in Myrtle Beach is real, and it connects directly to the ingredient opportunity we’re building this series around.

If you want the phytochemical profile documentation and the sourcing story to build your formula narrative, reach out at muscadineproducts.com.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. References to muscadine phytochemical profile are based on published compositional and nutritional research. Formulators should consult qualified regulatory counsel before establishing label claims for finished consumer products. Muscadine Products Corporation • Wray, Georgia • muscadineproducts.com

July 9, 2026July 9, 2026

Muscadine and Cardiovascular Health: What the Research Shows and Why It Matters for Your Formula

If you’re developing a cardiovascular supplement, you already know the challenge: the category is competitive, consumers are sophisticated, and retailers and practitioners have seen enough weak science to ask tough questions. You need an ingredient with a solid research story behind it — not a mechanistic rationale dressed up as clinical evidence.

Muscadine is that ingredient. It has a documented phytochemical profile featuring compounds that appear throughout the polyphenol-vascular research literature, a peer-reviewed human trial specifically on muscadine grape seed and cardiovascular markers, and a fully traceable domestic estate supply chain. That’s a combination most cardiovascular botanical ingredients on the market can’t match.

Here’s what that research shows — and how to use it honestly in your formula.

The Problem Formulators Bring to Us

The formulators who come to us are looking for a cardiovascular ingredient that does three things: connects to published research, has a traceable supply chain, and gives their brand a story that holds up when a buyer or practitioner asks the right questions.

Muscadine addresses all three. The phytochemical profile is documented. A human trial exists, and we’ll tell you exactly what it found. Paulk Vineyards grows muscadines on 800+ acres in Wray, Georgia — seventh generation on the farm, fourth with muscadines — with MPC processing everything on-site. One supply chain. No brokers.

That gap is where brands get caught — in a retailer’s science review, a practitioner’s due diligence, or a direct question from a consumer who reads labels. The brands that hold up in this category long term are those that built on honest research foundations from the start.

The Research Context Muscadine Brings to the Table

Muscadine’s phytochemical profile — anthocyanins, OPCs, ellagic acid, and resveratrol — places it squarely within the class of compounds most extensively studied for vascular health. A 2022 systematic review published in Nutrients (Grosso et al.) examined human studies on dietary polyphenol consumption and its associations with vascular health, blood pressure, and hypertension.

The review found that some polyphenol-rich food categories — particularly those rich in anthocyanins — show evidence of an association with blood pressure outcomes, and that anthocyanin intake was consistently associated with reduced hypertension risk across prospective cohort data — an epidemiological finding, not a clinical claim about any specific supplement product.* The proposed mechanisms include nitric oxide bioavailability, support for endothelial function, and antioxidant activity in vascular tissue.

Muscadine contains all of those compound classes. The review examined dietary polyphenols broadly, not muscadine specifically — and that distinction matters for how you use this research in a label-claim context. But it establishes a meaningful scientific framework for why muscadine’s profile warrants a formulator’s attention in this category.

(See the full disclaimer at the end of this post regarding the scope of these findings.) The distinction matters. A formulator should not cite this review as clinical evidence that a muscadine supplement supports cardiovascular health. It provides a research framework — both mechanistic and epidemiological — showing that the class of compounds found in muscadine has been studied in relation to vascular health. That’s a legitimate research context. It is not a finished clinical claim.

The Muscadine Human Trial: Honest, Peer-Reviewed, and Worth Knowing

The Mellen et al. study (Journal of the American College of Nutrition, 2010) is the most directly relevant published human trial on muscadine and cardiovascular markers. It’s a randomized, double-blind, placebo-controlled crossover trial — one of the most rigorous study designs in nutritional science. The trial included 50 adults with coronary disease or at least one cardiac risk factor. Muscadine grape seed supplementation was 1,300 mg daily for four weeks.

We’re going deeper into that study next week: the full methodology, what the secondary finding does and doesn’t mean, and how a formulator should approach positioning an ingredient whose best clinical trial produced a null primary result.

What Muscadine Gives a Cardiovascular Formulator

We understand the commercial pull of this category — cardiovascular is one of the largest supplement markets, and consumers are actively seeking products. The challenge is building something you can stand behind when the questions get hard. An honest cardiovascular formula story looks like this:

A phytochemical profile — anthocyanins, OPCs, ellagic acid, and resveratrol — with documented presence in the polyphenol-vascular research literature
A peer-reviewed, randomized, placebo-controlled human trial focused specifically on muscadine grape seed — with outcomes accurately disclosed, including the null primary endpoint
A fully traceable domestic estate supply chain: Paulk Vineyards grows, MPC processes, no brokers, and full lot documentation
An ingredient partner who will provide you with the research, the documentation, and an honest account of what it shows — so your regulatory team can build claims that hold up

Request a sample, review the Mellen study documentation, or schedule a sourcing call at muscadineproducts.com.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The Grosso et al. (2022) review examined dietary polyphenol consumption and vascular health broadly across human studies; findings reflect associations observed in the reviewed literature and do not constitute evidence that any specific muscadine ingredient product produces cardiovascular health benefits. The Mellen et al. (2010) study examined muscadine grape seed supplementation in a cardiovascular risk population; the primary outcome was not statistically significant. Formulators should consult qualified regulatory counsel before establishing label claims for finished consumer products. Muscadine Products Corporation • Wray, Georgia • muscadineproducts.com

June 30, 2026

Where We Left Off: Closing Out Antioxidants and Opening Cardiovascular Health

We missed a couple of weeks in this series. My son got married, and that took priority over the publishing calendar — no apology needed for that trade, and I’d make it again.

Rather than backfill two posts that have already lost their moment, we’re picking up the series where it matters most: closing out June’s antioxidant theme with the piece that ties it together and opening July with what’s next. If you want the OPC and ellagic acid stack content or the deeper estate-sourcing piece we’d originally planned for mid-June, reach out — we’re happy to send that material directly.

Closing Out Antioxidants: The Sourcing Argument

Everything we covered this month came back to the same point: a defensible antioxidant formula needs a mechanistic story, not just an ORAC number. Ellagic acid, OPCs, resveratrol, and anthocyanins — the muscadine phytochemical profile — connect to documented oxidative stress pathways in published research, including UV-relevant mechanisms studied in human skin cell models.

The sourcing side of that story is just as important as the science. Muscadine Seed Extract and Extract Powder come from Paulk Vineyards, the growing operation — 800+ acres in Wray, Georgia, seventh generation on the farm, fourth generation with muscadines. Muscadine Products Corporation processes everything on-site. No brokers between the vine and the ingredient lot. When a formulator builds a claim on a specific mechanism and a traceable source, that claim holds up in a way a generic antioxidant blend usually doesn’t.

That’s where we left it.

Opening Cardiovascular: Starting With Honest Research

Cardiovascular health is one of the most scrutinized categories in the supplement industry, and it deserves that scrutiny. Claims in this space are held to the real clinical literature more often than in almost any other category because the stakes for consumers are higher.

The most directly relevant published human research on muscadine and cardiovascular outcomes is the Mellen et al. study (Journal of the American College of Nutrition, 2010). It’s worth knowing exactly what that study found before we go further into July, because we’re not going to build this month’s content on a study we haven’t represented accurately.

Here’s the honest summary: 50 adults with coronary disease or at least one cardiac risk factor received 1,300 mg of muscadine grape seed supplement daily or placebo for four weeks each in a randomized, double-blind, crossover design. The primary outcome — flow-mediated dilation, a measure of endothelial function — did not show a statistically significant improvement. There was a significant increase in resting brachial artery diameter with muscadine grape seed supplementation, but the study authors explicitly stated that the clinical significance of this finding has not yet been established.

Primary endpoint (FMD): not statistically significant

Secondary finding (resting brachial diameter): statistically significant increase; clinical significance not established
No significant changes in biomarkers of inflammation, lipid peroxidation, or antioxidant capacity
Study authors’ conclusion: more research is needed to fully characterize the vascular effects of muscadine and other grape-derived supplements and to determine whether those effects translate into clinical benefit

We’re telling you this upfront because it’s the responsible way to open a month built around cardiovascular claims — and because a cardiovascular ingredient story built on a misread study is the kind of thing that falls apart the moment a retailer’s science team or a practitioner asks a follow-up question. The study does not support a cardiovascular benefit claim for muscadine grape seed supplementation. (These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.) What it does establish is that muscadine grape seed has been studied in a real, peer-reviewed, randomized trial in a cardiovascular risk population. That puts it in different territory than most botanical ingredients marketed for heart health. Most of those have no human trial data to back them up at all.

Over the next few weeks, we’ll delve deeper into that study, the broader polyphenol-vascular research landscape, and how a formulator should approach positioning an ingredient with this kind of research profile — real, peer-reviewed, and not yet conclusive.

If you want the full Mellen study citation and methodology to start that conversation with your R&D team, reach out at muscadineproducts.com.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The Mellen et al. (2010) study examined muscadine grape seed supplementation in subjects with coronary disease or cardiac risk factors; the primary outcome measure did not reach statistical significance, and the clinical significance of the secondary finding has not been established. This research does not constitute evidence of a cardiovascular health benefit. Formulators should consult qualified regulatory counsel before establishing label claims for finished consumer products. Muscadine Products Corporation • Wray, Georgia • muscadineproducts.com

June 8, 2026

UV Exposure, Oxidative Stress, and What It Means for Your Antioxidant Formula

Early June over the vines in the morning.

Creating a trustworthy antioxidant formula in today’s market can be quite challenging. You often see many claims, but the actual science behind most of them isn’t as clear. If you haven’t considered the role of UV oxidative stress, you might be missing out on addressing one of the most relevant seasonal factors.

UV rays from the sun, particularly UVA and UVB, cause skin to produce reactive oxygen species (ROS). These are the same free radicals that antioxidant ingredients aim to combat. The link between UV exposure, oxidative stress, and the value of dietary antioxidant supplements is one of the strongest mechanistic arguments we have. However, many antioxidant formulas don’t target this connection specifically with their choice of ingredients.

Formulators who can clearly connect UV oxidative stress to a particular ingredient’s mechanism will likely stand out in the competitive antioxidant market.

The Mechanism Worth Understanding

UV radiation can cause oxidative stress by penetrating skin tissue and producing reactive oxygen species (ROS) like superoxide anion, hydrogen peroxide, and hydroxyl radicals. These reactive molecules can overwhelm the skin’s natural antioxidant defenses, leading to the damage of lipids, proteins, and DNA. This process results in inflammation, weakened skin barrier, and faster aging—what many people refer to as “sun damage.”

Research has shown that dietary polyphenols such as ellagitannins, proanthocyanidins, and anthocyanins—found in muscadine grapes—may help protect against UV-induced oxidative stress, DNA damage, and skin inflammation through various mechanisms. (Saraf et al., Food & Function, 2017)

This is the kind of scientific understanding your antioxidant product should be based on. Instead of just looking at a single ORAC score, focus on the underlying mechanisms that show how oxidative stress affects the body.

What the Ellagic Acid Research Shows — and Its Limits

Ellagic acid, a natural compound found richly in muscadine skin and seeds, has been carefully studied for its effects on human skin cells, specifically in models using HaCaT cells, which simulate human keratinocytes. In these studies, pre-treating the cells with ellagic acid was shown to lower UVA-induced oxidative stress by reducing reactive oxygen species (ROS) and activating the body’s natural antioxidant defenses via the Nrf-2 pathway.*

Why Muscadine’s Profile Fits This Application

Muscadine (Vitis rotundifolia) offers a rich combination of beneficial compounds like ellagic acid, OPCs (oligomeric proanthocyanidins), resveratrol, and anthocyanins—all in a single, whole-plant ingredient. Each of these compounds has been highlighted in polyphenol research related to photoprotection. Instead of relying on a single compound, you’re working with a diverse phytochemical profile that influences multiple well-documented mechanisms.

For formulators creating an antioxidant, anti-aging product especially suited for summer use, this profile provides a scientifically backed explanation of how oxidative stress operates—not just a vague claim that the ingredient “fights free radicals.”

The sourcing story further strengthens this. Paulk Vineyards cultivates muscadines on over 800 acres in Wray, Georgia—continuing a seventh-generation family tradition, with the farm being four generations deep in muscadine cultivation. MPC processes all the ingredients right on-site. When your customers ask where the ingredient comes from, you can confidently share a real, transparent answer.

Application Notes

Muscadine Skin/Seed Powder and Muscadine Seed Extract are capsule and tablet ingredients. They are insoluble and not appropriate for beverage, RTD, or stick-pack formulations.
If your antioxidant formula includes a liquid application, Muscadine Juice Concentrate is the relevant form. It delivers polyphenols in liquid format for RTD and functional beverage applications.
For label claim development: the in vitro ellagic acid research supports a mechanistic rationale, not a finished human clinical claim. Work with your regulatory counsel to establish appropriate structure/function language based on the compound-level research and any additional studies your team identifies.

The Honest Summary

The connection between UV exposure, oxidative stress, and dietary polyphenols is one of the more credible mechanistic arguments in the antioxidant supplement category. Muscadine’s ellagic acid content places it directly in the relevant research area. The cell-level science is real and published. The human clinical evidence at the ingredient level isn’t there yet— and we won’t tell you otherwise. What we can tell you is that the science behind muscadine’s profile is more thoroughly documented than that of most antioxidant ingredients we encounter in the market, and the sourcing story is fully traceable. If your R&D team wants the ellagic acid content data and the research citations to start that conversation, reach out at muscadineproducts.com.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Research references cited herein include in vitro cell culture studies and published review literature. Cell-level findings do not establish that a finished supplement product will produce the same effects in humans. Formulators should consult qualified regulatory counsel before establishing label claims for finished consumer products. Muscadine Products Corporation • Wray, Georgia • muscadineproducts.com

June 2, 2026June 2, 2026

Antioxidant Sourcing in Summer: Why June Is When Formulators Should Be Asking Harder Questions

The antioxidant supplement category has a sourcing problem that peaks in summer.

Not because the science changes — it doesn’t. But because the consumer purchase signal peaks in summer, and that means brands are launching, reformulating, and sourcing in Q2 in a way that creates real pressure on ingredient decisions. The antioxidant supplement market is one of the most crowded shelves in the industry. It’s also one of the categories where the gap between what a label claims and what an ingredient actually delivers is widest.

If your antioxidant formula is going to hold up — with a retailer, with a practitioner, with a consumer reading labels — the sourcing decision matters more than the marketing language. That’s what this month is about.

The Antioxidant Ingredient Credibility Problem

Most antioxidant supplements are built around ORAC scores and vague polyphenol claims. ORAC — oxygen radical absorbance capacity — is a lab measure of antioxidant potential in a test tube. It is not a measure of what happens in the human body after digestion, absorption, and distribution. The FDA actually discouraged the use of ORAC values in food and supplement labeling back in 2012, removing them from its own database. Most of the industry kept using them anyway.

What matters for a formulator who wants a defensible antioxidant ingredient is more specific than a single number: which polyphenol subfractions are present, at what concentrations, with what documented mechanisms, and from what verified source.

We’ve been growing muscadines in Irwin County since 1970 and processing them on-site since the early days of the ingredient market. We’ve watched a lot of antioxidant formulas come and go, and the ones that lose shelf space almost always share the same problem: they were built on a marketing claim that couldn’t answer a simple question from a buyer who knew what to ask. Muscadine’s answer to those questions is one of the more distinctive in the botanical ingredient market. The phytochemical profile — ellagic acid, OPCs, resveratrol, and anthocyanins — provides multiple antioxidant mechanisms through different documented pathways. That matters for a formulator because it means you’re not staking your entire antioxidant story on a single compound that a competitor can match with a cheaper alternative.

What the Research Shows — Accurately

There is published human research relevant to muscadine and oxidative stress worth knowing about. Ghanim et al. (Journal of Clinical Endocrinology & Metabolism, 2011) studied a combination supplement containing resveratrol and muscadine grape polyphenols. Researchers observed a reduction in oxidative and inflammatory stress markers following a high-fat, high-carbohydrate meal, and noted stimulation of the antioxidant transcription factor Nrf-2.*

Three things to hold onto about that study for formulation purposes:

The supplement studied was a combination of resveratrol and muscadine polyphenols — not muscadine extract alone. The muscadine component contributed to the effect; the study design doesn’t isolate it.
The study context was a meal challenge — measuring oxidative stress response to a specific dietary insult. That’s a meaningful and real-world relevant context, but it’s different from a general antioxidant supplementation trial in a healthy population.
The Nrf-2 activation finding is the most mechanistically interesting part of that study. Nrf-2 is the antioxidant transcription factor that regulates the body’s own antioxidant enzyme systems. That’s a different category of mechanism than basic radical scavenging — and worth understanding if your R&D team is building a differentiated antioxidant formula.

Frame it that way with your regulatory team when you’re evaluating label claim options. The mechanism is real. The evidence is peer-reviewed. The scope is what it is, and your claims need to reflect that scope.

The Polyphenol Profile as a Formulation Asset

Muscadine (Vitis rotundifolia) is structurally distinct from Vitis vinifera — the conventional wine grape most polyphenol ingredients derive from. The ellagic acid concentration in muscadine skin and seed is notably higher than most vinifera comparators. The OPC subfraction profile is structurally different from standard grape seed extract or pine bark, with a different monomer-to-polymer ratio that affects both mechanism and bioavailability questions.

For a formulator building an antioxidant SKU, that profile gives you claims you can actually defend — specific, factual, and not shared by commodity polyphenol ingredients:

A distinct botanical species with documented phytochemical differentiation from conventional grape
Ellagic acid content relevant to the urolithin-A research area — one of the more active fields in antioxidant and longevity science right now
OPCs with a different structural profile than standard GSE
A domestic estate supply chain with full lot traceability — not a commodity broker import

Application Notes for June Formulation

Before you spec any of this into a formula, a few things to get right from the start:

Muscadine Skin/Seed Powder and Muscadine Seed Extract are not soluble. These are capsule and tablet ingredients only. Do not spec them into a beverage, RTD, or stick pack formula.
Muscadine Juice Concentrate is available for liquid antioxidant applications. It delivers polyphenols in liquid form and is appropriate for RTD and functional beverage formulations.
Both Skin/Seed Powder and Seed Extract are available with lot-level CoA documentation. If your QA team needs standardized ellagic acid or OPC data for each lot, contact us — we can discuss what’s available.

What’s Coming This Month

The next three weeks cover the UV oxidative stress connection for summer formulas, the OPC and ellagic acid combination as a specific stack, and the estate sourcing story that sits underneath all of it. If you want to get ahead of any of that now — samples, CoA documentation, or a sourcing call — don’t wait.

If you want to get ahead of any of this — samples, technical documentation, or a sourcing conversation — visit muscadineproducts.com.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Research references are cited for informational and educational purposes only. The Ghanim et al. (2011) study examined a combination supplement containing resveratrol and muscadine grape polyphenols in a meal-challenge context; findings should not be extrapolated to muscadine extract alone or to general antioxidant supplementation outcomes. Formulators should consult qualified regulatory counsel before establishing label claims for finished consumer products. Muscadine Products Corporation • Wray, Georgia • muscadineproducts.com

May 26, 2026

What the Banini Study Actually Shows — and What It Doesn’t

Last week, we made a commitment: to tell you what the research on muscadine actually shows, including where it stops. This week, we’re following through.

The Banini study is the most directly relevant published human trial on muscadine and metabolic markers. Here’s exactly what it was, what it found, and where its limits lie.

The Study at a Glance

Banini AE, Boyd LC, Allen JC, Allen HG, and Sauls DL. “Muscadine grape products intake, diet and blood constituents of non-diabetic and type 2 diabetic subjects.” Nutrition, 2006; 22(11–12):1137–1145. North Carolina State University.

Element	Detail
Study	Banini AE et al., Nutrition 2006; 22(11–12):1137–1145
Institution	North Carolina State University, Raleigh, NC
Design	Non-randomized, non-blinded dietary intervention; 28 days
Population	Type 2 diabetic subjects (assigned to MJ, MW, or Dz-W) and non-diabetic subjects (juice only)
Intervention	150 mL/day of muscadine grape juice (MJ), muscadine grape wine (MW), or dealcoholized muscadine grape wine (Dz-W) with meals
Primary outcomes	Glycemic indices, blood glucose, insulin, glycated hemoglobin (HbA1c), lipid profile, blood constituents
Key findings	Diabetics given MW and Dz-W showed lower blood glucose, insulin, and HbA1c vs. diabetics given MJ. Dz-W group: fasting blood insulin reduced; glucose:insulin ratio improved from 8.5 to 13.1. MJ and MW did not differ in fasting glucose, insulin, or HbA1c in the non-diabetic group.
Study limitation	Non-diabetic group received juice only — no wine or Dz-W arm. No placebo control. Cannot compare non-diabetic outcomes to diabetic outcomes across product types.

What It Found

The most meaningful findings came from Type 2 diabetic subjects assigned to muscadine wine and dealcoholized muscadine wine. Compared with diabetics given muscadine juice, those groups had lower blood glucose, insulin, and glycated hemoglobin levels over the 28-day period.

The dealcoholized wine group — the arm most relevant to a supplement context, since alcohol is removed — showed a specific improvement in fasting blood insulin levels. The fasting blood glucose-to-insulin ratio rose from 8.5 to 13.1 over the intervention period. The researchers noted that a ratio below 7 is considered predictive of insulin resistance; the published data showed movement away from that threshold in the T2D group over 28 days.

These are real findings from a real peer-reviewed study in a population where metabolic markers matter most.

What It Doesn’t Show

Here is where we’re going to be direct, because this is where ingredient marketing most often goes wrong.

The non-diabetic subjects in this study received only muscadine juice. There was no wine or dealcoholized wine arm for healthy subjects, and no placebo control for that group. You cannot draw conclusions about muscadine’s effect on healthy adults’ metabolic markers from this study design.

The intervention used whole beverage forms — 150 mL of juice, wine, or dealcoholized wine per day. This is not the same as a standardized extract powder or capsule. The polyphenol dose, bioavailability, and matrix context of a beverage differ from those of an encapsulated ingredient. Extrapolating these findings to a capsule product requires additional research.

28 days is a short intervention window. These findings are a signal worth taking seriously, not a conclusion about long-term metabolic outcomes.

This was not a randomized, blinded, placebo-controlled trial — the design most likely to produce generalizable results. The findings are meaningful and peer-reviewed, but the study design has limitations that should inform how confidently you cite it.

Why This Still Matters for Formulators

Here’s why it still matters.

Many metabolic health ingredients have limited or no peer-reviewed human research. Their evidence base often rests on mechanistic rationale — in vitro studies showing that a compound interacts with a relevant pathway in cell culture, which is a long way from a human outcome. The Banini study, with its clearly stated limitations, still places muscadine in a category most competing ingredients cannot enter.

This research also holds up when a retailer or practitioner asks the right question — not “what does your marketing say?” but “what does your best published human study actually show?” We can answer that with a citation, a methodology, and an honest account of what was and wasn’t found. That’s a more defensible position than most suppliers in this category can offer.

The Right Application

Given what this study used, the MPC ingredient form most directly relevant to this research context is Muscadine Juice Concentrate — the beverage-form polyphenol delivery that most closely mirrors what was studied. It is appropriate for liquid supplement applications and functional beverage formulations.

Muscadine Skin/Seed Powder — our encapsulated ingredient form — provides the same phytochemical profile in capsule or tablet applications. It is a non-soluble powder, appropriate for encapsulation, not for beverage blending. The phytochemical case for that form is strong; the direct clinical link to the Banini study is more attenuated, and we will not overstate it.

If your R&D team wants to review the full Banini citation, methodology, and published abstract, contact us and we’ll send them directly. We’d rather put the actual study in front of your team than a polished summary.

Next Week

The series moves to June’s theme: Skin Health / Beauty From Within. We’ll cover Muscadine Seed Oil and Skin Extract — two ingredients with a genuinely differentiated story for cosmetic formulators and ingestible beauty brands. If you want to be ready for that conversation, visit muscadineproducts.com to request a sample or technical documentation.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Research references are cited for informational and educational purposes. The Banini study was conducted in a Type 2 diabetic population using whole beverage forms of muscadine; findings should not be generalized to healthy populations or encapsulated ingredient forms without additional research. Formulators should consult qualified regulatory counsel before establishing label claims for finished consumer products. Muscadine Products Corporation • Wray, Georgia • muscadineproducts.com

May 17, 2026May 17, 2026

The Metabolic Health Supplement Market Has a Credibility Problem. Here’s What Honest Looks Like.

May on the vine in Wray, Georgia. The clusters are just setting. This is what estate-sourced looks like at the source.

If you’ve spent any time sourcing ingredients for the metabolic health category, you already know the problem.

The shelves — and the trade show floors — are full of formulas built on blood sugar and insulin sensitivity claims. Most of them are backed by in vitro studies, animal model data, or industry-sponsored trials that haven’t been independently replicated. A growing number of retailers, practitioners, and sophisticated consumers have noticed. They’re asking harder questions. And brands that built their metabolic formulas on overclaimed evidence are finding those questions uncomfortable to answer.

We’re launching this content series — Formulate with Purpose — because we think the ingredient sourcing conversation in this industry deserves more honesty than it usually gets. Starting here, in one of the categories where that problem is most visible.

What We Mean by Credibility

In the metabolic health ingredient market, credibility has two components that most ingredient marketing conflates: the science and the source.

The science question is: has this ingredient been studied in peer-reviewed human research, with a clearly defined study population, by researchers who weren’t paid by the ingredient supplier? And if so, what did those studies actually find — not what does the marketing summary claim they found?

The source question is: do you know where this ingredient was grown, how it was processed, and who handled it between the farm and your production facility? Or did you buy it from a broker who bought it from a distributor who sourced it from an overseas supplier whose growing practices you’ve never seen?

Both of those questions have uncomfortable answers for a lot of the metabolic health ingredient market right now. We’d rather address that directly than pretend otherwise.

The Muscadine Research: What It Shows and What It Doesn’t

Muscadine (Vitis rotundifolia) has been studied in peer-reviewed human research in a metabolic context. The most directly relevant published study — Banini et al. (Nutrition, 2006) — examined the effects of muscadine grape products on glycemic indices, lipid profiles, and blood constituents over a 28-day period.

The study population matters, and we’re going to tell you exactly what it was: Type 2 diabetic subjects, alongside a non-diabetic comparison group. The researchers observed improvements in several metabolic markers among diabetic subjects who consumed muscadine wine or dealcoholized wine, compared with those given muscadine juice.

That is an interesting finding in a disease-specific population using muscadine in beverage form. It is not evidence that a muscadine extract capsule will improve blood sugar in healthy adults, and we won’t frame it that way. We think you’d respect us less if we did.

What this research does tell us — honestly — is that muscadine polyphenols have been studied in a peer-reviewed human trial in a metabolic context. That puts muscadine in a different tier than metabolic ingredients whose entire evidence base is a cell culture study.

The Phytochemical Case

Muscadine contains ellagic acid, oligomeric proanthocyanidins (OPCs), resveratrol, and anthocyanins in documented concentrations. These compounds have been studied in nutritional science for their potential roles in supporting various physiological functions.*

The ellagic acid concentration in muscadine skin and seed is notably high compared to most vinifera-derived comparators — a documented analytical fact, not a marketing claim. The OPC subfraction profile is structurally distinct from conventional grape seed or pine bark extract, which affects both the mechanism and bioavailability questions that your R&D team should be asking.

We’ll go deeper on the compound-level science in the weeks ahead. For now, the point is this: the phytochemical profile gives formulators a mechanistic rationale for why muscadine is worth investigating. It is not, by itself, a finished clinical credential for a label claim.

The Sourcing Case

Here is where we can speak without any qualification at all.

Paulk Vineyards grows muscadines on more than 800 acres of estate farmland in Wray, Georgia in Irwin County. Seventh-generation family farming. Muscadine Products Corporation produces all of the ingredients on our family farm. We own the land, we run the harvest, and we process the fruit on-site. There are no brokers between the vine and the ingredient lot. This is family-owned & operated.

Every production run carries full lot traceability. We can document the growing practices, the harvest date, the processing method, and the analytical results for every lot we ship. If your QA team asks where the ingredient came from, we can show them, not just tell them.

In a market where most botanical ingredients pass through three or four broker hands before they reach a production facility — with origin documentation that ranges from thin to nonexistent — a fully traceable, domestic, estate-grown supply chain is not a small thing. It’s increasingly the difference between a brand story that holds up and one that doesn’t.

What’s Coming in This Series

Every week, this series will cover one topic relevant to formulators and ingredient buyers sourcing in the functional nutrition market: published research, sourcing frameworks, ingredient science, application guidance, and supply chain considerations.

We will tell you what the research shows. We will also tell you what it doesn’t show. We think that combination — honest science plus traceable sourcing — is what the market actually needs more of right now.

If you’d like to request a sample or review technical documentation, visit muscadineproducts.com. We’ll start with the data.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Research references are cited for informational and educational purposes. Clinical research findings reflect what was observed in the referenced study population and do not guarantee individual results. Formulators should consult qualified regulatory counsel before establishing label claims for finished consumer products. Muscadine Products Corporation • Wray, Georgia • muscadineproducts.com